Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) — Medica
Small Cell Lung Cancer – extensive-stage
Initial criteria
- age ≥ 18 years
- prescribed by or in consultation with an oncologist
Approval duration
1 year
Small Cell Lung Cancer – extensive-stage
1 year